CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients
J Ma, L Yang, H Feng, L Zheng… - Journal of Clinical …, 2021 - Wiley Online Library
Objective Chaperonin‐containing tailless complex polypeptide subunit 6A (CCT6A) is a
critical regulator and newly identified clinical biomarker of several cancers, while its …
critical regulator and newly identified clinical biomarker of several cancers, while its …
EIF3B is associated with poor outcomes in gastric cancer patients and promotes cancer progression via the PI3K/AKT/mTOR signaling pathway
L Wang, X Wen, F Luan, T Fu, C Gao, H Du… - Cancer Management …, 2019 - Taylor & Francis
Purpose Eukaryotic translation initiation factor (EIF) plays a vital role in protein synthesis.
EIF3B is a core subunit of the EIF3 family, and is overexpressed in many tumors. EIF3B is …
EIF3B is a core subunit of the EIF3 family, and is overexpressed in many tumors. EIF3B is …
[HTML][HTML] An inter-correlation among chemokine (CXC motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and …
L Gu, Y Yao, Z Chen - Translational Cancer Research, 2021 - ncbi.nlm.nih.gov
Background The aim was to explore the interaction among chemokine (CXC motif) ligand
(CXCL) 1/2/8 expressions, and their associations with clinicopathologic features and …
(CXCL) 1/2/8 expressions, and their associations with clinicopathologic features and …
Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis
C Wang, X **e, W Li, D Jiang - Journal of Clinical Laboratory …, 2022 - Wiley Online Library
Background Kinesin family member 2A (KIF2A), nuclear division cycle 80 (NDC80), cyclin‐
dependent kinase 1 (CDK1), and cyclin B1 (CCNB1) exhibit a complex interrelation, which …
dependent kinase 1 (CDK1), and cyclin B1 (CCNB1) exhibit a complex interrelation, which …
A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer
D Wang, Y Luo, Y Guo, G Li… - The International Journal …, 2020 - journals.sagepub.com
Objective: This study aimed to investigate the correlation of A-kinase interacting protein 1
(AKIP1) with chemokine (CXC motif) ligand 1 (CXCL1) and CXCL2, as well as their …
(AKIP1) with chemokine (CXC motif) ligand 1 (CXCL1) and CXCL2, as well as their …
Eukaryotic translation initiation factor 3 subunit B promotes head and neck cancer via CEBPB translation
C Xu, Y Shen, Y Shi, M Zhang, L Zhou - Cancer Cell International, 2022 - Springer
Background Head and neck squamous cell carcinoma (HNSCC) is the sixth most common
cancer type worldwide. Deregulation of mRNA translation is a frequent feature of cancer …
cancer type worldwide. Deregulation of mRNA translation is a frequent feature of cancer …
EIF3B promotes cancer progression in pancreatic cancer
H Zhu, Y Shan, K Ge, J Lu, W Kong… - Scandinavian Journal of …, 2021 - Taylor & Francis
Background This study aimed to analyze the relative expression of Eukaryotic Translation
Initiation Factor 3 Subunit B (EIF3B) in pancreatic cancer and elucidate its contribution to this …
Initiation Factor 3 Subunit B (EIF3B) in pancreatic cancer and elucidate its contribution to this …
TEX9 and eIF3b functionally synergize to promote the progression of esophageal squamous cell carcinoma
F Xu, S Zhang, Z Liu, J Gu, Y Li, L Wang, W Mao, Q Zhu… - BMC cancer, 2019 - Springer
Background Esophageal squamous cell carcinoma (ESCC) is one of the most frequent
malignant digestive tumors around the world. We previously demonstrated that eIF3b could …
malignant digestive tumors around the world. We previously demonstrated that eIF3b could …
High-mobility group box 2 reflects exacerbated disease characteristics and poor prognosis in non-small cell lung cancer patients
N Lou, T Zhu, D Qin, J Tian, J Liu - Irish Journal of Medical Science (1971 …, 2022 - Springer
Background High-mobility group box 2 (HMGB2) is considered as oncogene in non-small
cell lung cancer (NSCLC), while its clinical implication is still unknown. This study aimed to …
cell lung cancer (NSCLC), while its clinical implication is still unknown. This study aimed to …
Guanylate‐binding protein 1 correlates with advanced tumor features, and serves as a prognostic biomarker for worse survival in lung adenocarcinoma patients
Q Wan, J Qu, L Li, F Gao - Journal of Clinical Laboratory …, 2021 - Wiley Online Library
Objective Guanylate‐binding protein 1 (GBP1) is reported to promote tumor progression and
treatment resistance in lung cancer, and presents as a prognostic biomarker in several solid …
treatment resistance in lung cancer, and presents as a prognostic biomarker in several solid …